Biden’s Drug Czar Wants To Make It Easier To Research Marijuana, Psychedelics And Other Schedule I Substances

MJ moment

The Biden administration proposed a change to the federal drug scheduling system on Thursday that it hopes will streamline research into Schedule I controlled substances including marijuana and psychedelics such as psilocybin. The White House Office of National Drug Control Policy (ONDCP) said in a letter to congressional leaders and a plan posted on the agency’s website that it wants to encourage research in part by simplifying the registration process for scientists to access Schedule I drugs so that they match those for less-restricted Schedule II substances. This is part of a broader White House initiative to develop what it says is a strategy to reduce the supply of illicit fentanyl analogues, while “protecting civil rights, and reducing barriers to scientific research for all schedule I substances.” Health experts have widely criticized the existing registration system as unduly onerous—particularly when it comes to Schedule I substances—and they’ve said it has inhibited research. Nora Volkow, director of the National Institute on Drug Abuse (NIDA), has described the current process as “lengthy and cumbersome.” Today, the Biden-Harris Administration presented to Congress recommendations for a long-term, consensus approach to reduce illicitly manufactured fentanyl-related substances, while protecting civil rights and encouraging scientific research. — ONDCP (@ONDCP) September 2, 2021 ONDCP said that what it wants to do is “align research registration for all schedule I substances more closely with the research registration process for schedule II substances.” “The Biden-Harris Administration strongly supports expanding the research of [fentanyl-related substances] and other schedule I substances to help advance evidence-based public policy,” it said. Under the current process, both Schedule I and Schedule II DEA registration applications must include a general research proposal, information on storage and security, and experience and qualifications to conduct the studies. For applicants seeking access to Schedule I drugs, however, there’s…

Excerpt only …
Source : Biden’s Drug Czar Wants To Make It Easier To Research Marijuana, Psychedelics And Other Schedule I Substances

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.